Loading...
DOCUMENTS
80
NOTICES
153
MOTS CLES
Biosimilar Pharmaceuticals
Psoriatic arthritis
Amyloidosis
Pharmacoepidemiology
Management
BTK protein
Treatment
Pharmacovigilance
Biologic drug
Epidemiology
Antimicrobial resistance
Méta-Analyse
Ankylosing spondylitis
Sipuleucel-T
Placebo
Antimicrobiens
Cardiovascular therapy
Antibiotics
Anti-TNF
Intensive care
Infliximab
Axial spondyloarthritis
Psoriasis
Adalimumab
Graft-versus-host disease
Biomédicaments
Cancer
Anticancer drugs
Albinism
Biomarkers
Adolescent
Cardiomyopathy
Biological Therapy
Primary adrenal insufficiency
Apremilast
Dermatology
Antibiotic resistance
Biological therapy
Quality of life
Aging
Glucocorticoids
ASDAS
Anxiété
Access to care
Abus d'antibiotiques
Azathioprine
Biologic therapy
Cattle
Immune-related adverse events
Ankylosing
Spondyloarthritis
Ethics
Atrial fibrillation
Etanercept
COVID-19
CSK tyrosine-protein kinase
Immune checkpoint inhibitors
Immunotherapy
Endocrine toxicity
Auto-immune hepatitis
Anxiety
Antimicrobials
Prostate cancer
Cardio-oncology
Adverse side effects
Atopic dermatitis
Burden
Cardiotoxicity
Vigibase®
Stability
Ustekinumab
ArtThese
Acute Myeloid Leukaemia AML
Addiction
Calcium channel blockers
Sacroiliitis
Biologic
Biologics
Arthritis
Meta-Analysis
Alitretinoin
Autoimmune diseases
Antibiotic misuse
Alcohol
Apre-milast
Anti-HCV Direct Acting Antivirals DAA
Cardiovascular risk
Beta-lactam antibiotics
Auto-Diagnostic
Arrhythmia
Drug reaction
Bacterial rhinosinusitis
Care pathway
Case-Control Studies
Drug survival
CTLA-4
Angiotensin receptor blockers
Accelerometer
Angiotensin-converting enzyme inhibitors
Autoimmunity
Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379 | |
---|---|
Adresse |
Université Paris-Est Créteil Val de Marne (UPEC) Campus Centre de Créteil |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Émilie SBIDIAN |
Axe(s) de recherche
|
|
COLLABORATIONS
|